AbbVie Inc (ABBV)
164.99
-4.64
(-2.74%)
USD |
NYSE |
Nov 15, 16:00
165.15
+0.16
(+0.10%)
After-Hours: 20:00
AbbVie Shares Outstanding: 1.767B for Oct. 28, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 28, 2024 | 1.767B |
September 30, 2024 | 1.767B |
July 29, 2024 | 1.766B |
June 30, 2024 | 1.766B |
April 25, 2024 | 1.766B |
March 31, 2024 | 1.766B |
March 04, 2024 | 1.771B |
January 31, 2024 | 1.766B |
December 31, 2023 | 1.766B |
October 27, 2023 | 1.766B |
September 30, 2023 | 1.765B |
July 31, 2023 | 1.765B |
June 30, 2023 | 1.765B |
April 25, 2023 | 1.764B |
March 31, 2023 | 1.764B |
March 06, 2023 | 1.764B |
January 31, 2023 | 1.769B |
December 31, 2022 | 1.769B |
October 26, 2022 | 1.768B |
September 30, 2022 | 1.768B |
July 27, 2022 | 1.768B |
June 30, 2022 | 1.768B |
April 27, 2022 | 1.767B |
March 31, 2022 | 1.767B |
March 07, 2022 | 1.766B |
Date | Value |
---|---|
January 31, 2022 | 1.769B |
December 31, 2021 | 1.768B |
October 25, 2021 | 1.768B |
September 30, 2021 | 1.768B |
July 26, 2021 | 1.767B |
June 30, 2021 | 1.767B |
April 28, 2021 | 1.766B |
March 31, 2021 | 1.766B |
March 08, 2021 | 1.765B |
January 31, 2021 | 1.766B |
December 31, 2020 | 1.765B |
October 27, 2020 | 1.765B |
September 30, 2020 | 1.765B |
July 28, 2020 | 1.765B |
June 30, 2020 | 1.764B |
May 08, 2020 | 1.762B |
April 30, 2020 | 1.477B |
March 31, 2020 | 1.477B |
March 13, 2020 | 1.477B |
January 31, 2020 | 1.479B |
December 31, 2019 | 1.479B |
October 29, 2019 | 1.479B |
September 30, 2019 | 1.479B |
July 29, 2019 | 1.478B |
June 30, 2019 | 1.478B |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
1.477B
Minimum
Mar 13 2020
1.771B
Maximum
Mar 04 2024
1.735B
Average
1.766B
Median
Shares Outstanding Benchmarks
Amgen Inc | 537.53M |
Johnson & Johnson | 2.408B |
Eli Lilly and Co | 949.32M |
Merck & Co Inc | 2.530B |
Pfizer Inc | 5.667B |